Jagsonpal Pharmaceuticals allots new shares under ESOP 2022

Jagsonpal Pharmaceuticals Limited announced the allotment of 56,571 equity shares on November 18, 2025, as part of its JPL ESOP 2022. These shares, with a par value of ₹2 each, were issued to eligible employees who exercised their vested options, and will rank pari-passu with existing equity shares.

This allotment has increased the company's paid-up share capital from ₹13,34,49,398 (representing 6,67,24,699 equity shares) to ₹13,35,62,540 (representing 6,67,81,270 equity shares). The shares were issued at exercise prices ranging from ₹94.00 to ₹115.60 per share, with corresponding premiums of ₹92.00 to ₹113.60.

The allotment includes 46,246 equity shares at ₹94.00, 9,125 equity shares at ₹113.60, and 1,200 equity shares at ₹115.60. The company’s shares are listed on the BSE Limited and the National Stock Exchange of India Limited.